# Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108

> **NCT07153172** · PHASE1 · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 91 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** INV-347

## Key facts

- **NCT ID:** NCT07153172
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-06
- **Primary completion:** 2027-09-15
- **Final completion:** 2027-09-15
- **Target enrollment:** 91 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07153172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07153172, "Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07153172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*